Oxycodone/ibuprofen

Drug Profile

Oxycodone/ibuprofen

Alternative Names: Combunox

Latest Information Update: 15 Jul 2015

Price : $50

At a glance

  • Originator Bristol-Myers Squibb
  • Developer Allergan; Bristol-Myers Squibb
  • Class Analgesics; Morphine derivatives; Phenylpropionates
  • Mechanism of Action Cyclooxygenase inhibitors; Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain

Most Recent Events

  • 01 Jul 2014 Forest Laboratories has been acquired by Actavis Inc
  • 21 Mar 2005 Launched for Pain in USA (PO)
  • 29 Nov 2004 Registered for Pain in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top